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Transcatheter aortic valve replacement is a promising new technique to treat patients with 
severe aortic stenosis due to its minimally invasive approach. Unfortunately, higher 
levels of thrombosis from utilizing this device instead of a standard surgical aortic valve 
means further research is needed to understand the cause. In order to understand areas of 
flow stasis and accurately model local flow patterns, a coronary flow model was 
developed which produces more physiologically accurate flow conditions than aortic 
flow models without this feature. Two experiments were performed, with and without the 
coronary, and hemodynamic and particle image velocimetry (PIV) data were collected. 
The results showed differences in the magnitude and flow patterns between the two cases 
during systole. Relevant applications of this system include studying the effect of 










Approximately 1.5 million Americans suffer from aortic stenosis (AS), the 
narrowing of the aortic valve opening.1 Over time, calcium (a mineral found in the 
blood), may accumulate on the aortic valve cusps. This process, known as calcification 
often results in the stiffening of the leaflets.2 This stiffening prevents the aortic valve 
from fully opening, thereby increasing the resistance the left ventricle must overcome in 
order to eject blood into the aorta.2 To make up for this loss, the ventricle compensates by 
pumping harder. In severe cases, aortic stenosis requires a valve replacement surgery.  
 For patients with severe symptomatic AS who are classified high surgical risk or 
inoperable, there is a new approach called transcatheter aortic valve replacement 
(TAVR).3 This procedure is performed percutaneously via catheter and the valve is 
deployed in a manner similar to a stent deployment. The valve is positioned within the 
native valve, pushing the calcified leaflets out of the way. This technique is very 
promising as it does not require open heart surgery, however further research needs to be 
conducted so that any complications and negative long term effects can be minimized. 
One review of the most relevant complications associated with TAVR elucidates 
several issues related to the coronary arteries, which supply blood to the heart muscle.4 
Malpositioning of the valve can lead to blocking of the coronary ostia. The correct 
anatomical location of valve deployment is within the aortic annulus so a deployment that 
is too deep (specific values vary based on patient anatomy) may block or alter flow 
patterns near the coronaries which are downstream of the annulus. Additionally, certain 
surgical techniques such as using a larger-diameter prosthesis may improve the 
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attachment between the prosthesis and the annulus thereby reducing the risk of 
paravalvular leak; however, this method would increase the risk of embolizing the debris 
from the calcified valve into the coronary arteries. Furthermore, recent studies which 
examine clinical data of TAVR patients have shown that the cases of valve thrombosis, 
the development of blood clots, are higher than expected.5-9 It is still unknown what leads 
to these higher levels of thrombosis, but it has been shown that hemodynamics play a key 
role in its progression.10-12 With valve malpositioning being a known issue, this may 
result in abnormal flow patterns in and around the valve, thereby leading to stagnation of 
flow and ultimately a pro-thrombogenic environment. 
In order to better understand the progression of thrombosis post-TAVR, 
researchers have developed several in vitro and computational models to simulate 
pulsatile blood flow through the aortic valve.13-15 Laadhari employs mathematical and 
computational modeling to study the incidence of blood stagnation after TAVR in the 
two-dimensional case.13 Vahidkhah performs an in vitro assessment of aortic valve 
hemodynamics along with computer simulations of the flow field.14 Ducci shows via an 
in vitro study that transcatheter aortic valves alter the physiological blood flow, and may 
lead to thromboembolic events.15 These studies, although thorough, do not incorporate 
the coronary arteries into their models. As a result, they do not capture the complete 
hemodynamic profile of the aortic sinus. Therefore, a model which incorporates the 
coronary arteries would aid in the process of understanding thrombosis development in 
TAVR patients. 
Some previous studies have incorporated the coronary arteries into their models in 
an effort to achieve a more physiologically accurate model. Moore and Dasi constructed a 
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time-varying Windkessel chamber in order to model the effect of systolic coronary 
constriction.16 Querzoli uses a water-filled chamber to simulate the compression of the 
coronary by the cardiac muscle.17 Calderan et al. utilized a two-way stopcock valve 
controlled with a stepper motor via a LabView program.18 These studies have begun to 
show the effects of including the coronary arteries in aortic valve modeling however such 
models have yet to be applied to transcatheter aortic valves so. A more recent study does 
begin to quantify coronary velocity with a transcatheter aortic valve in place and 
compares this case to a non-coronary case. The study reveals that velocity through the 
sinus is reduced in the case without the coronary and that peak shear stress is higher 
along the aortic side of the coronary when compared to the non-coronary experiment.19 
Further, more extensive research is still needed to fully understand the impact of TAVR 
on hemodynamics and what this means in clinical applications.  
To better understand regions of flow stasis which may contribute to thrombosis 
development, a more physiologically accurate model is required to model local flow 
patterns through the aortic sinus. Therefore, the aim of this study is to create a 
physiologically relevant left heart simulator with coronary artery flow. A fully 
controllable and physiological coronary waveform is produced using a programmable 
variable pinch valve representing coronary resistance. A particle image velocimetry 
(PIV) experiment shows a difference between the model with and without coronary flow. 
This model can be used in future studies to understand blood flow patterns in the aorta 




Georgia Tech Left Heart Simulator 
 The Georgia Tech Left Heart Simulator (GTLHS) is a pulsatile flow loop that has 
been validated to mimic physiological hemodynamic conditions of the heart (Figure 1). 
Aortic valves to be tested can be mounted within the valve chamber which is idealized, 
rigid, and created to simulate the aortic root and proximal ascending aorta of a healthy 
adult. Physiologic aortic and ventricular pressures were attained by tuning the lumped 
resistance and compliance elements in the system which represent systemic vascular 
compliance and resistance. The bladder pump, which models the left ventricle, was 
controlled through a system of solenoid valves. The timing of the solenoid valves was 
controlled by a custom LabVIEW vi (National Instruments Corporation, Austin, TX). 
The GTLHS was tuned to a cardiac output of 5.0 L/min, aortic pressures of 120/80 
mmHg, and a cardiac cycle length of 856 ms. Flow and pressure data was measured using 
an electromagnetic flow probe (Carolina Medical Electronics, East Bend, NC) and two 
pressure transducers (Validyne Engineering Corp, Northridge, CA). Data were acquired 




Figure 1. Flow Loop Diagram – Shows a schematic of the GTLHS with coronary 
addition. 
Coronary Flow Model 
 In the aortic flow chamber described above, a 4 mm coronary ostium was added 
17 mm above the aortic annulus. The coronary ostia location and size represents a patient 
average location based on previous studies .20-21 Figure 2 displays the model 
representation of the aortic sinus including a 27 mm Trifecta surgical aortic valve (St. 
Jude Medical, Saint Paul, Minnesota) and the coronary ostium.  In order to mimic the 
coronary constriction that occurs from myocardial contraction, time-varying resistance 
was imposed on the coronary artery using a proportional pinch valve and stepper motor 
(ResolutionAir, Cincinnati, OH). The proportional pinch valve was wired to the stepper 
drive (Figure 3). The drive has two inputs (direction and step) which were wired to the 
analog output channels of a data acquisition system (cDAQ, National Instruments 
Corporation, Austin, TX). The stepper motor was connected to a 12-40V DC power 
source (BK Precision Corporation, Yorba Linda, CA). The cDAQ was connected to a 
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laptop which contained a custom LabVIEW code, which controls the oscillatory motion 
of the pinch valve. The frequency was set to 1.17 Hz to match the timing of the cardiac 
cycle. Coronary flow data was collected using an ultrasonic flow probe (Transonic 
Systems Inc., Ithaca, NY). Specific waveforms were produced in LabVIEW and used to 
control the stepper motor which controlled the direction and step of the pinch valve 
(Figure 4). 
 
Figure 2. Aortic Valve Chamber - Aortic valve chamber with Trifecta surgical valve in 
place and coronary ostium. 
 
Figure 3. Proportional Pinch Valve and Stepper Drive – (a) Proportional pinch valve used 
for the coronary experiments to mimic systolic constriction of the coronary. (b) Stepper 
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drive used to control proportional pinch valve (adapted from 
http://www.resolutionair.com). 
 
Figure 4. LabVIEW vi - (a) LabVIEW code used to send specific waveforms to the 
stepper motor and control the pinch valve. (b) Direction and pulse train waveforms 
produced by the LabVIEW code to control the pinch valve. 
 
Hemodynamics 
Experiments with and without a coronary artery were performed to collect and 
compare hemodynamic data of the two cases using a 27 mm Trifecta surgical aortic valve 
(St. Jude Medical, Saint Paul, Minnesota). Mean transvalvular pressure gradient, and 
effective orifice area were hemodynamic metrics calculated from the aortic pressure, 
ventricular pressure, and aortic flow data recorded from the validated LHS. Mean 
transvalvular pressure is the pressure gradient across the valve representing the difference 
in pressure between the left ventricle and aorta. Effective orifice area is the minimal 
cross-sectional area of flow downstream of the aortic valve. It is calculated using the 
following equation:  where QRMS is the forward flow during the period 
of positive pressure differential, ΔP is the mean pressure gradient, and ρ is the test fluid 
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density. These metrics are used to assess the severity of aortic stenosis in patients.22-23 
High pressures and low orifice areas indicate more severe cases of aortic stenosis.  
 
Particle Image Velocimetry 
Phase-locked PIV was used to investigate the effect of left coronary artery flow 
on the aortic sinus velocity field. PIV is a flow visualization technique which allows for 
the motion of neutrally buoyant particles to be quantified across a region of interest. The 
PIV experiments in this study yielded two-dimensional, two-component measurements. 
The working fluid used was a 3.5 cP saline-glycerine solution, 36% glycerin by volume 
in water, in order to match the kinematic viscosity of blood. The solution was seeded 
with fluorescent particles (PMMA with RhB dye, 1-20 µm, Dantec Dynamics; Denmark) 
which were illuminated using a laser sheet of 1 mm thickness generated from a Nd:YAG 
laser (New Wave laser, 532 nm, ESI Inc.; Portland OR). The particles were imaged with 
a CCD camera (LaVision, Germany, Imager ProX, 1600 × 1200 pixels). Two 
experiments were performed using a 27 mm Trifecta surgical aortic valve (St. Jude 
Medical, Saint Paul, Minnesota) with and without the coronary addition. The purpose of 
the experiments was to demonstrate any effect of the coronary on the flow field through 
the sinus. Data was collected at five different time points (0ms, 175ms, 300ms, 500ms, 
700ms) throughout the cardiac cycle representing end diastole, peak systole, valve 
closure, peak coronary flow, and mid-diastole. Data at each timepoint was averaged over 
200 cardiac cycles. PIV data processing was performed using DaVis 8.0 (LaVision 




Two t-tests were performed in order to assess the significance of any differences 
between the hemodynamic data of the two experimental cases (with and without 
coronary). The mean transvalvular pressure gradient and the effective orifice area were 





















The experiment without the coronary was used as a baseline and produced a mean 
transvalvular pressure of 1.79 ± 0.194 mmHg while the coronary case produced a mean 
transvalvular pressure of 1.93 ± 0.264 mmHg (p = 0.15). Additionally, effective orifice 
area was 4.18 ± 0.18 cm2 and 4.27 ± 0.24 cm2 for the non-coronary and coronary cases, 
respectively (p = 0.24). 
 The aortic and coronary waveforms are shown in Figure 2. The first peak of the 
coronary flow rate waveform reaches a value of 0.3 L/min, reduces to 0.2 L/min, and 
then reaches a second peak value of 0.35 L/min. The curve then gradually declines to a 




Figure 5. Experimental Flow Profiles – Aortic flow (solid line) and coronary flow 
(dashed line) averaged over 15 cardiac cycles. 
 
Particle Image Velocimetry 
Figures 6 and 7 compare flow through the aorta with and without the coronary 
addition at 5 different time points throughout the cardiac cycle. The color of the flow 
field indicates the magnitude and arrows indicate the direction of flow. At the end of 
diastole for both the coronary and non-coronary experiments, flow is quiescent with 
maximum velocities of 0.1 m/s or less. At peak systole, forward jet (velocities greater 
than 1m/s) encompasses almost the entire aorta in both cases. By valve closure, the 
magnitude of flow has decreased with both cases containing maximum velocity 
magnitudes of 0.5 m/s. During early diastole (t=500 ms) and mid-diastole (t=700 ms), the 







Figure 6. PIV Comparisons – Images show flow through the aorta at five different timepoints 
throughout the cardiac cycle (0ms, 175ms, 300ms, 500ms, 700ms) without (left column) and with 
(right column) the coronary model included. The color of the flow field indicates the magnitude, 
with red representing higher velocity flow (1 m/s) and blue representing lower velocity flow (0 
m/s). Arrows point in the direction of flow. 
 
At timepoints 175 ms and 300 ms, flow is directed toward the coronary ostium at 
slightly elevated velocities. At 175 ms, the velocity of flow without the coronary is nearly 
0 m/s whereas this velocity is increased to 0.2 m/s once the coronary is incorporated 
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(Figure 8). This difference in velocity magnitude also occurs at 300 ms with a magnitude 
of 0.1 m/s for the non-coronary case and increasing to 0.3 m/s in the coronary case 
(Figure 9). Furthermore, at timepoint 500 ms, there are some key differences in the 
direction of the flow field of the coronary and non-coronary experiments. In the non-
coronary experiment, there is an apparent vortex formed at the tip of the valve leaflet. On 
the other hand, the coronary experiment has flow pointing not toward the valve, but into 
the coronary ostium (Figure 9). Additionally, at the final timepoint, 700 ms (mid-
diastole), the flow field is very quiescent in both cases since flow through the coronary is 
zero at this point in the cardiac cycle.  
 
Figure 7. Peak Systole Comparison – Displays side-by-side comparison of non-coronary 
(left) and coronary (right) PIV experiments at 175 ms (peak systole).  
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Figure 8. Valve Closure Comparison – Shows side-by-side comparison of non-coronary 
(left) and coronary (right) PIV experiments at 300 ms (valve closure). 
 
Figure 9. Early Diastole Comparison - Shows side-by-side comparison of non-coronary (left) and 








Hemodynamic metrics from each experimental condition were shown to not be 
statistically significantly different. This establishes that the system produces equivalent 
experimental environments for the non-coronary and coronary cases making PIV results 
directly comparable. Additionally, based on the hemodynamic results of the two 
experiments, the mean transvalvular pressure and the effective orifice area values are 
consistent with published values of the Trifecta valve.24  
A physiological coronary flow waveform is characterized by two peaks during the 
cardiac cycle. The initial peak, is the result of a rapid increase in the aortic pressure at the 
start of systole. Flow decreases when the myocardium is fully contracted, thereby 
constricting the coronary. The second peak arises during diastole as a result of 
myocardial relaxation which reduces resistance in the coronary. At the end of the 
waveform, flow steadily reduces to zero as aortic pressure decreases during diastole. 
Average physiological flow through the coronary during the cardiac cycle is 125 mL/min. 
Based on the results, the experimental system produced a waveform which is 
characterized by two peaks and thus matches the physiological expectations. 
PIV experiments aided in elucidating the flow patterns and magnitudes in the 
sinus with and without the coronary. The addition of the coronary artery model resulted 
in changes in the flow field during peak and end systole in the region of interest, above 
the coronary. At peak systole, blood is being ejected from the left ventricle and in the 
region flowing into the coronary artery, the velocity magnitude is higher in the coronary 
case than the non-coronary case. This is logical because in the coronary case, blood can 
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flow continuously and unimpeded into the coronary and therefore produce higher 
magnitude flow in the region of interest. At valve closure (end systole), there is a similar 
region of higher magnitude flow near the coronary ostium in the coronary case than in the 
non-coronary case. The regions of higher magnitude flow in the coronary case 
correspond to the elevated coronary flow rates that occur during systole. The difference is 
further supported by directional arrows pointing into the location of the coronary ostium 
during systole for the coronary case but not the non-coronary case. During diastole, the 
flow fields between the two cases are comparable. This is logical because flow through 
the coronary is zero during diastole so it should not have an impact on the flow field 
















One limitation of this study stems from the timing characteristics of the timed 
coronary resistance component. The results showed a small peak in coronary flow after 
reaching zero however, physiologically, the flow should remain zero until systole. This 
slight error in the waveform arises from a hardware limitation meaning a pinch valve 
with a faster response time would allow for a more physiologically accurate time-varying 
resistance. Therefore, the proportional pinch valve timing system must be further 
optimized in order to produce a more physiologically accurate waveform. However, the 
results of this study demonstrate the feasibility of this system to generate physiologically 




This study established a system which mimics coronary constriction during 
systole, thereby producing more physiologically accurate flow within the aortic sinus of 
the GTLHS. Finally, differences in flow magnitude and pattern were shown in 
experiments which compared cases with and without the addition of the coronary model. 
Further research on this system is needed to optimize the timing settings of the pinch 
valve system. Relevant applications of this system may be studying the effect of coronary 
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